Furthermore, patients in stages II and III were reported to have increased expression of Lcn-2 in the tumor stroma, compared to healthy tissue, and patients with metastatic breast cancer were reported to have increased expression of Lcn-2 in the urine [104]. Here, LCN2 is linked to neoplasm.